| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
|
N Engl J Med
|
1990
|
5.27
|
|
2
|
Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
|
Gene Ther
|
2002
|
2.59
|
|
3
|
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.
|
Nat Med
|
2000
|
2.09
|
|
4
|
Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet?
|
J Hematother
|
1999
|
1.45
|
|
5
|
Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
|
Proc Natl Acad Sci U S A
|
1990
|
1.36
|
|
6
|
Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells.
|
Hum Gene Ther
|
1990
|
1.32
|
|
7
|
Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.
|
Exp Hematol
|
1996
|
1.26
|
|
8
|
Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections.
|
Am J Med
|
1995
|
1.17
|
|
9
|
Analysis of retroviral packaging lines for generation of replication-competent virus.
|
Virology
|
1990
|
1.13
|
|
10
|
Lymphocytes as cellular vehicles for gene therapy in mouse and man.
|
Proc Natl Acad Sci U S A
|
1991
|
1.10
|
|
11
|
Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
|
Ann Hematol
|
1995
|
1.09
|
|
12
|
Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
2001
|
1.07
|
|
13
|
High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer.
|
J Clin Oncol
|
2000
|
1.02
|
|
14
|
Retroviral-mediated gene transfer.
|
Prog Nucleic Acid Res Mol Biol
|
1990
|
1.02
|
|
15
|
Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation.
|
Blood
|
1994
|
1.02
|
|
16
|
The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.
|
J Immunol
|
2000
|
1.01
|
|
17
|
Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic.
|
Cancer Res
|
1995
|
1.00
|
|
18
|
High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors.
|
Science
|
1989
|
1.00
|
|
19
|
Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area.
|
Transpl Infect Dis
|
2002
|
0.97
|
|
20
|
Information preferences, reading ability, and emotional changes in outpatients during the process of obtaining informed consent for autologous bone-marrow transplantation.
|
J Cancer Educ
|
1998
|
0.97
|
|
21
|
Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep.
|
Blood
|
1993
|
0.96
|
|
22
|
Rapid titer determination using quantitative real-time PCR.
|
Gene Ther
|
1999
|
0.95
|
|
23
|
The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
|
Biochem Biophys Res Commun
|
2000
|
0.94
|
|
24
|
Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource.
|
Gene Ther
|
2008
|
0.94
|
|
25
|
In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys.
|
Hum Gene Ther
|
1990
|
0.94
|
|
26
|
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
|
Cancer
|
1997
|
0.90
|
|
27
|
Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
|
Virology
|
2001
|
0.90
|
|
28
|
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
|
Am J Clin Pathol
|
1997
|
0.89
|
|
29
|
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
|
Gene Ther
|
2009
|
0.89
|
|
30
|
Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
|
Hum Gene Ther
|
2001
|
0.88
|
|
31
|
High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
|
Bone Marrow Transplant
|
2001
|
0.87
|
|
32
|
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
|
Bone Marrow Transplant
|
2010
|
0.87
|
|
33
|
Comparison of single- versus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity.
|
J Pharmacol Exp Ther
|
2001
|
0.87
|
|
34
|
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
|
Blood
|
1998
|
0.87
|
|
35
|
Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
|
Hum Gene Ther
|
2000
|
0.87
|
|
36
|
Gene transfer into primates and prospects for gene therapy in humans.
|
Prog Nucleic Acid Res Mol Biol
|
1989
|
0.84
|
|
37
|
Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
|
Med Pediatr Oncol
|
1998
|
0.84
|
|
38
|
Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.
|
Cancer Res
|
1997
|
0.84
|
|
39
|
Human gene marker/therapy clinical protocols.
|
Hum Gene Ther
|
2000
|
0.84
|
|
40
|
Clinical retroviral vector production: step filtration using clinically approved filters improves titers.
|
Gene Ther
|
2000
|
0.83
|
|
41
|
Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells.
|
Br J Haematol
|
1998
|
0.82
|
|
42
|
A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.
|
Gene Ther
|
2012
|
0.81
|
|
43
|
Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action.
|
Hum Gene Ther
|
1999
|
0.81
|
|
44
|
Increased efficiency of retroviral-mediated gene transfer and expression in primate bone marrow progenitors after 5-fluorouracil-induced hematopoietic suppression and recovery.
|
Blood
|
1991
|
0.81
|
|
45
|
Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors.
|
Biochem Biophys Res Commun
|
1990
|
0.80
|
|
46
|
Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
|
Bone Marrow Transplant
|
1998
|
0.79
|
|
47
|
Human gene marker/therapy clinical protocols.
|
Hum Gene Ther
|
1999
|
0.79
|
|
48
|
Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells.
|
Cancer Immunol Immunother
|
1991
|
0.79
|
|
49
|
Bone marrow cytolysis induced by hepatoma, teratocarcinoma, and transformed fibroblasts.
|
Cancer Res
|
1979
|
0.79
|
|
50
|
Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes.
|
Blood
|
1998
|
0.79
|
|
51
|
Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
|
Clin Cancer Res
|
1998
|
0.78
|
|
52
|
Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1994
|
0.78
|
|
53
|
Tandem autotransplantation for the treatment of metastatic breast cancer.
|
J Clin Oncol
|
1995
|
0.78
|
|
54
|
The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors.
|
Leukemia
|
1997
|
0.77
|
|
55
|
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
|
Bone Marrow Transplant
|
1995
|
0.77
|
|
56
|
Human gene marker/therapy clinical protocols.
|
Hum Gene Ther
|
1997
|
0.76
|
|
57
|
Forced over-expression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells.
|
Leukemia
|
1996
|
0.76
|
|
58
|
Human gene marker/therapy clinical protocols.
|
Hum Gene Ther
|
1996
|
0.76
|
|
59
|
Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model.
|
Prog Clin Biol Res
|
1994
|
0.76
|
|
60
|
Gene therapy strategies for leukemia.
|
Mol Med Today
|
1997
|
0.76
|
|
61
|
Organ distribution of circulating very low density lipoproteins (VLDL): fate of hematopoietic growth inhibitory VLDL in the rat.
|
Exp Hematol
|
1983
|
0.76
|
|
62
|
Antileukemic activity of Flt3 ligand in murine leukemia.
|
Cancer Res
|
2000
|
0.76
|
|
63
|
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
|
Br J Cancer
|
1998
|
0.75
|
|
64
|
Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
65
|
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
|
Bone Marrow Transplant
|
2000
|
0.75
|
|
66
|
Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
|
Bone Marrow Transplant
|
1997
|
0.75
|
|
67
|
Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
|
Cancer Gene Ther
|
1997
|
0.75
|
|
68
|
Autologous bone marrow transplantation.
|
Crit Rev Clin Lab Sci
|
1995
|
0.75
|
|
69
|
Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
70
|
Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
71
|
Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells.
|
J Hematother
|
1999
|
0.75
|
|
72
|
Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture.
|
Stem Cells
|
1998
|
0.75
|
|
73
|
Human gene marker/therapy clinical protocols.
|
Hum Gene Ther
|
1996
|
0.75
|
|
74
|
Platelet loss during peripheral blood progenitor cell collections.
|
Transfus Sci
|
1996
|
0.75
|
|
75
|
Large-scale mobilization and isolation of CD34+ cells from normal donors.
|
Bone Marrow Transplant
|
2000
|
0.75
|